Caption Management, LLC Invitae Corp Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $138,663 - $586,551	-65,100 Reduced 52.04%	60,000 $146,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.27 Million - $1.97 Million	-48,800 Reduced 28.06%	125,100 $4.22 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $23.6 Million - $40.6 Million	-713,000 Reduced 80.39%	173,900 $6.65 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $29.8 Million - $43.7 Million	761,900 Added 609.52%	886,900 $37.1 Million
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $2.49 Million - $3.91 Million	87,500 Added 233.33%	125,000 $5.42 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $57,300 - $206,250	7,500 Added 25.0%	37,500 $512,000
Q2 2019 Aug 13, 2019	BUY	$17.37 - $26.27 $521,100 - $788,100	30,000 New	30,000 $705,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.